vs
Side-by-side financial comparison of ARGENX SE (ARGX) and AMERICAN AXLE & MANUFACTURING HOLDINGS INC (AXL). Click either name above to swap in a different company.
ARGENX SE is the larger business by last-quarter revenue ($2.5B vs $1.4B, roughly 1.8× AMERICAN AXLE & MANUFACTURING HOLDINGS INC). ARGENX SE runs the higher net margin — 35.5% vs -5.4%, a 40.9% gap on every dollar of revenue. On growth, ARGENX SE posted the faster year-over-year revenue change (83.2% vs 0.2%). ARGENX SE produced more free cash flow last quarter ($322.4M vs $54.7M).
AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. They have produced drugs to treat a wide range of medical issues.
American Axle & Manufacturing, Inc. (AAM), headquartered in Detroit, Michigan, is an American manufacturer of automobile driveline and drivetrain components and systems.
ARGX vs AXL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $2.5B | $1.4B |
| Net Profit | $877.2M | $-75.3M |
| Gross Margin | 89.5% | 10.2% |
| Operating Margin | 28.9% | -2.4% |
| Net Margin | 35.5% | -5.4% |
| Revenue YoY | 83.2% | 0.2% |
| Net Profit YoY | 1.3% | -449.6% |
| EPS (diluted) | $13.25 | $-0.62 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $2.5B | $1.4B | ||
| Q3 25 | — | $1.5B | ||
| Q2 25 | $1.8B | $1.5B | ||
| Q1 25 | — | $1.4B | ||
| Q4 24 | $1.4B | $1.4B | ||
| Q3 24 | — | $1.5B | ||
| Q2 24 | $901.9M | $1.6B | ||
| Q1 24 | — | $1.6B |
| Q4 25 | $877.2M | $-75.3M | ||
| Q3 25 | — | $9.2M | ||
| Q2 25 | $414.8M | $39.3M | ||
| Q1 25 | — | $7.1M | ||
| Q4 24 | $865.6M | $-13.7M | ||
| Q3 24 | — | $10.0M | ||
| Q2 24 | $-32.5M | $18.2M | ||
| Q1 24 | — | $20.5M |
| Q4 25 | 89.5% | 10.2% | ||
| Q3 25 | — | 12.6% | ||
| Q2 25 | 89.2% | 13.1% | ||
| Q1 25 | — | 12.3% | ||
| Q4 24 | 90.2% | 11.2% | ||
| Q3 24 | — | 11.4% | ||
| Q2 24 | 89.4% | 13.3% | ||
| Q1 24 | — | 12.4% |
| Q4 25 | 28.9% | -2.4% | ||
| Q3 25 | — | 3.2% | ||
| Q2 25 | 19.2% | 3.6% | ||
| Q1 25 | — | 3.0% | ||
| Q4 24 | 8.7% | 2.6% | ||
| Q3 24 | — | 2.8% | ||
| Q2 24 | -15.4% | 5.3% | ||
| Q1 24 | — | 4.8% |
| Q4 25 | 35.5% | -5.4% | ||
| Q3 25 | — | 0.6% | ||
| Q2 25 | 23.4% | 2.6% | ||
| Q1 25 | — | 0.5% | ||
| Q4 24 | 64.1% | -1.0% | ||
| Q3 24 | — | 0.7% | ||
| Q2 24 | -3.6% | 1.1% | ||
| Q1 24 | — | 1.3% |
| Q4 25 | $13.25 | $-0.62 | ||
| Q3 25 | — | $0.07 | ||
| Q2 25 | $6.32 | $0.32 | ||
| Q1 25 | — | $0.06 | ||
| Q4 24 | $13.33 | $-0.11 | ||
| Q3 24 | — | $0.08 | ||
| Q2 24 | $-0.55 | $0.15 | ||
| Q1 24 | — | $0.17 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.5B | $708.9M |
| Total DebtLower is stronger | — | $4.0B |
| Stockholders' EquityBook value | $7.3B | $640.0M |
| Total Assets | $8.7B | $6.7B |
| Debt / EquityLower = less leverage | — | 6.31× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.5B | $708.9M | ||
| Q3 25 | — | $714.1M | ||
| Q2 25 | $2.1B | $586.5M | ||
| Q1 25 | — | $549.2M | ||
| Q4 24 | $1.5B | $552.9M | ||
| Q3 24 | — | $542.5M | ||
| Q2 24 | $1.4B | $519.9M | ||
| Q1 24 | — | $469.8M |
| Q4 25 | — | $4.0B | ||
| Q3 25 | — | $2.6B | ||
| Q2 25 | — | $2.6B | ||
| Q1 25 | — | $2.6B | ||
| Q4 24 | — | $2.6B | ||
| Q3 24 | — | $2.6B | ||
| Q2 24 | $11.0M | $2.7B | ||
| Q1 24 | — | $2.7B |
| Q4 25 | $7.3B | $640.0M | ||
| Q3 25 | — | $718.4M | ||
| Q2 25 | $6.1B | $673.0M | ||
| Q1 25 | — | $596.3M | ||
| Q4 24 | $5.5B | $562.8M | ||
| Q3 24 | — | $616.3M | ||
| Q2 24 | $4.3B | $609.6M | ||
| Q1 24 | — | $621.4M |
| Q4 25 | $8.7B | $6.7B | ||
| Q3 25 | — | $5.3B | ||
| Q2 25 | $7.2B | $5.3B | ||
| Q1 25 | — | $5.1B | ||
| Q4 24 | $6.2B | $5.1B | ||
| Q3 24 | — | $5.3B | ||
| Q2 24 | $4.8B | $5.3B | ||
| Q1 24 | — | $5.4B |
| Q4 25 | — | 6.31× | ||
| Q3 25 | — | 3.61× | ||
| Q2 25 | — | 3.86× | ||
| Q1 25 | — | 4.38× | ||
| Q4 24 | — | 4.58× | ||
| Q3 24 | — | 4.28× | ||
| Q2 24 | 0.00× | 4.42× | ||
| Q1 24 | — | 4.40× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $323.3M | $120.5M |
| Free Cash FlowOCF − Capex | $322.4M | $54.7M |
| FCF MarginFCF / Revenue | 13.0% | 4.0% |
| Capex IntensityCapex / Revenue | 0.0% | 4.8% |
| Cash ConversionOCF / Net Profit | 0.37× | — |
| TTM Free Cash FlowTrailing 4 quarters | $594.5M | $155.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $323.3M | $120.5M | ||
| Q3 25 | — | $143.3M | ||
| Q2 25 | $361.8M | $91.9M | ||
| Q1 25 | — | $55.9M | ||
| Q4 24 | $41.9M | $151.2M | ||
| Q3 24 | — | $143.6M | ||
| Q2 24 | $-124.7M | $142.8M | ||
| Q1 24 | — | $17.8M |
| Q4 25 | $322.4M | $54.7M | ||
| Q3 25 | — | $79.2M | ||
| Q2 25 | $356.6M | $34.6M | ||
| Q1 25 | — | $-13.4M | ||
| Q4 24 | $40.9M | $73.2M | ||
| Q3 24 | — | $70.4M | ||
| Q2 24 | $-125.5M | $94.0M | ||
| Q1 24 | — | $-30.2M |
| Q4 25 | 13.0% | 4.0% | ||
| Q3 25 | — | 5.3% | ||
| Q2 25 | 20.1% | 2.3% | ||
| Q1 25 | — | -0.9% | ||
| Q4 24 | 3.0% | 5.3% | ||
| Q3 24 | — | 4.7% | ||
| Q2 24 | -13.9% | 5.8% | ||
| Q1 24 | — | -1.9% |
| Q4 25 | 0.0% | 4.8% | ||
| Q3 25 | — | 4.3% | ||
| Q2 25 | 0.3% | 3.7% | ||
| Q1 25 | — | 4.9% | ||
| Q4 24 | 0.1% | 5.6% | ||
| Q3 24 | — | 4.9% | ||
| Q2 24 | 0.1% | 3.0% | ||
| Q1 24 | — | 3.0% |
| Q4 25 | 0.37× | — | ||
| Q3 25 | — | 15.58× | ||
| Q2 25 | 0.87× | 2.34× | ||
| Q1 25 | — | 7.87× | ||
| Q4 24 | 0.05× | — | ||
| Q3 24 | — | 14.36× | ||
| Q2 24 | — | 7.85× | ||
| Q1 24 | — | 0.87× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ARGX
Segment breakdown not available.
AXL
| Driveline | $748.4M | 54% |
| Other | $345.7M | 25% |
| Metal Forming | $289.8M | 21% |
